• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.20% Nasdaq Down 0.17%

    Incyte Corporation (INCY)

    -NasdaqGS
    108.14 Up 0.22(0.20%) May 28, 4:00PM EDT
    Add to Portfolio
    Prev Close:107.92
    Open:107.92
    Bid:N/A
    Ask:109.50 x 100
    1y Target Est:117.30
    Beta:0.17
    Earnings Date:Jul 29 - Aug 3 (Est.)
    Day's Range:106.11 - 108.69
    52wk Range:43.86 - 111.93
    Volume:639,191
    Avg Vol (3m):1,179,600
    Market Cap:19.36B
    P/E (ttm):N/A
    EPS (ttm):-0.19
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    INCYUp 0.20%19.36B
    AMGNDown 1.93%119.64B
    CELGDown 0.94%91.16B
    RHHBYUp 1.38%N/A

    Key Statistics

    Forward P/E (1 yr):121.51
    P/S (ttm):33.26
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.26
    Quarterly EPS Est (Jun-15) :-0.11
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):-4.95

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics primarily for oncology. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback